. 2022 Mar 22;50(6):1668–1678. doi: 10.1177/03635465221083693
© 2022 The Author(s)
This article is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 License (https://creativecommons.org/licenses/by-nc-nd/4.0/) which permits non-commercial use, reproduction and distribution of the work as published without adaptation or alteration, without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
Figure 1.
Overview of the experimental setup. TAA, triamcinolone acetonide.